ASH 2022 Conference Coverage
ASH 2022 GRIFFIN Trial Final Analysis: D-RVd in Clinically Relevant Subgroups of Transplant-Eligible Newly Diagnosed MM
By
ASH 2022 Conference Coverage
FEATURING
Ajai Chari
By
ASH 2022 Conference Coverage
FEATURING
Ajai Chari
Login to view comments.
Click here to Login